# Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

Study · id `cardio:ct-nct01076088` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01076088](<https://clinicaltrials.gov/study/NCT01076088>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01076088

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 744 participants.

## Technical summary

Registry record NCT01076088. Randomized; double masking; primary purpose treatment. Start 2010-11-15 (actual); primary completion 2012-12-24 (actual). Results posted on 2014-02-06.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 744 participants (enrolled count; ClinicalTrials.gov record NCT01076088, source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)
- Started: 2010-11-15 (actual) (ClinicalTrials.gov record NCT01076088, source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)
- Primary completion: 2012-12-24 (actual) (ClinicalTrials.gov record NCT01076088, source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)
- Completion: 2012-12-24 (actual) (ClinicalTrials.gov record NCT01076088, source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)
- Results first posted: 2014-02-06 (ClinicalTrials.gov record NCT01076088, source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01076088-2017-05-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Sitagliptin 50 mg
- Intervention (Drug): Metformin 500 mg
- Intervention (Drug): Sitagliptin 100 mg
- Intervention (Drug): Placebo
- Intervention (Drug): Metformin 850 mg
- Lead sponsor: Merck Sharp & Dohme LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Merck Sharp & Dohme LLC (`cardio:org-merck-sharp-dohme-llc`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co-administered to Chinese patients with type 2 diabetes mellitus (`cardio:pubmed-27181998`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f4fc9e45656b1899b2be930764263717def57f7e57f80a6bfdc2b97524a2a3cf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
